Compound file

Tier 4: PeptideAnalysis pending

P21

P21 is a synthetic tetrapeptide derived from ciliary neurotrophic factor (CNTF) with an adamantylated glycine modification for enhanced blood-brain barrier penetration. Preclinical studies in mice demonstrate enhanced neurogenesis, synaptic plasticity, and cognitive benefits in Alzheimer's disease and traumatic brain injury models. No human clinical trials have been conducted.

← Browse all compounds